Ransohoff: Cologuard To Define the Roles of Colorectal Tests

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Addressing the Molecular and Genetics Screening Panel, David Ransohoff, coauthor of the NEJM paper, focused on the future role of noninvasive tests like Cologuard in programs of screening for colorectal cancer.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Mina Sedrak, director of the UCLA Center for Cancer and Aging and director of Cancer Control and Survivorship Research at the UCLA Health Jonsson Comprehensive Cancer Center, and Vijaya Raj Bhatt professor and medical director of the Leukemia Program at the University of Nebraska Medical Center, were selected to serve as co-chairs of the Cancer in the Older Adult Committee for The Alliance for Clinical Trials in Oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login